Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Moolec Science ( (MLEC) ) has issued an announcement.
On February 25, 2025, Moolec Science SA, a plant- and microbe-based protein innovator for the global food industry, announced a reshaping of its board of directors. The company appointed U.S.-based quality and operations veteran Daniel Core to its board, adding him to both the audit and compensation committees to bolster governance, compliance oversight, and operational risk management.
Effective the same day, directors Aimar Dimo and Gloria Montaron Estrada resigned from the board, marking a notable refresh of Moolec’s governance structure. The changes signal an increased emphasis on industrial-quality discipline and regulatory frameworks as the company advances its technology-driven, seed-to-ingredient strategy across its key markets in the United States, Europe, and South America.
The most recent analyst rating on (MLEC) stock is a Hold with a $17.50 price target. To see the full list of analyst forecasts on Moolec Science stock, see the MLEC Stock Forecast page.
Spark’s Take on MLEC Stock
According to Spark, TipRanks’ AI Analyst, MLEC is a Neutral.
The score is held back primarily by weak financial fundamentals—large losses, negative free cash flow, and a materially stressed balance sheet with negative equity and higher debt. Technicals are a partial offset with strong momentum and price above key moving averages, though the very high RSI indicates an overextended setup. Valuation is also constrained by negative earnings and no dividend support.
To see Spark’s full report on MLEC stock, click here.
More about Moolec Science
Moolec Science SA is a Nasdaq-listed food technology company that engineers plants and microbes to produce scalable protein solutions for the global food system. Combining Molecular Farming with precision fermentation, it develops alternative proteins, bioactive compounds, nutritional oils, and biological inputs for regenerative agriculture, supported by a portfolio of more than 52 granted and pending patents.
Average Trading Volume: 1,379,712
Technical Sentiment Signal: Sell
Current Market Cap: $11.41M
See more data about MLEC stock on TipRanks’ Stock Analysis page.